Lario Therapeutics
Biotechnology Research • 
United Kingdom • 1-10 Employees
Company overview
| Headquarters | United Kingdom |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Lario Therapeutics
Daniel Gill
Co-Founder and Head of Project Management
Lario Therapeutics Email Formats
Lario Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@lariotx.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@lariotx.com | 66.7% |
{first name} | john@lariotx.com | 33.3% |
About Lario Therapeutics
Lario Therapeutics is a company that develops precision medicines for severe neurological disorders including epileptic conditions and Parkinson’s disease. They have a rapidly advancing pipeline with genetically validated targets and promise broad therapeutic potential.
Lario Therapeutics revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Lario Therapeutics has never raised funding before.
Lario Therapeutics Tech Stack
Discover the technologies and tools that power Lario Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Hosting
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Spain
United States
South AfricaFrequently asked questions
4.8
40,000 users
